Healthcare Research Institute of Navarre (IdiSNA)
Instituto de Investigación Sanitaria de Navarra (IdiSNA)
Spain
1 October 2019 - 30 September 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Healthcare Research Institute of Navarre (IdiSNA) published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Healthcare Research Institute of Navarre (IdiSNA) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
11 | 2.12 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 10 | 2.03 | |
Chemistry | 1 | 0.09 |
Top articles by Altmetric score in current window
A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
Nature Communications
2020-02-18
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.
Cancer Cell
2019-11-06
Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model
Nature Communications
2019-12-13
Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies
Nature Communications
2020-04-08
1 October 2019 - 30 September 2020
International vs. domestic collaboration by Share
- 42.36% Domestic
- 57.64% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (13 total)
- Healthcare Research Institute of Navarre (IdiSNA), Spain
- Domestic institution
-
Institute of Health Carlos III (ISCIII), Spain
(2.34)
-
University of Barcelona (UB), Spain
(1.44)
-
Spanish National Research Council (CSIC), Spain
(1.07)
-
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain
(1.07)
-
Catalan Institution for Research and Advanced Studies (ICREA), Spain
(0.62)
-
La Fe University Hospital, Spain
(0.43)
-
Bellvitge Biomedical Research Institute (IDIBELL), Spain
(0.38)
-
Catalan Health Institute (ICS), Spain
(0.38)
-
Catalan Institute of Oncology (ICO), Spain
(0.31)
-
Fundació Clínic per a la Recerca Biomèdica, Spain
(0.30)
Top 10 international collaborators by Share (42 total)
- Healthcare Research Institute of Navarre (IdiSNA), Spain
- Foreign institution
-
Harvard University, United States of America (USA)
(0.92)
-
Vivet Therapeutics SAS, France
(0.82)
-
Rutgers, The State University of New Jersey (RU), United States of America (USA)
(0.64)
-
University of Gothenburg (GU), Sweden
(0.49)
-
University of Nantes, France
(0.47)
-
Ionis Pharmaceuticals, Inc., United States of America (USA)
(0.44)
-
University Hospital Nantes (CHU de Nantes), France
(0.37)
-
Laboratoire de Thérapie Génique, France
(0.37)
-
Center for Cancer Systems Biology (CCSB), United States of America (USA)
(0.35)
-
Radboud University Nijmegen (RU), Netherlands
(0.31)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
Healthcare Research Institute of Navarre (IdiSNA) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Clínica Universidad de Navarra (CUN), UNAV, Spain
- Complejo Hospitalario de Navarra (CHN), Spain
- Center for Applied Medical Research (CIMA), UNAV, Spain
- Miguel Servet Foundation, Spain
- Instituto de Salud Pública y Laboral de Navarra (ISPLN), Spain
- Public University of Navarre (UPNA), Spain
- Centro de Investigacións Mariñas (CIMA), Spain
- Biomedical Research Center of Navarre (Navarrabiomed), Spain
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.